Max Higgins, Consultant, Author at EverGlade Consulting

Blue digitally distorted brain illustration

ARPA-H Announces the Functional Repair of Neocortical Tissue (FRONT) Program

Leave a Comment / All Posts, ARPA-H, Life Sciences / By Max Higgins, Consultant

Functional Repair of Neocortical Tissue (FRONT) Health Science Futures (HSF) Innovative Solutions Opening (ISO) ARPA-H-SOL-25-120 July 10, 2025 Restoring the Damaged Brain: ARPA-H’s FRONT Program Targets Functional Neocortical Repair The Advanced Research Projects Agency for Health (ARPA-H) has announced an ambitious new program under its Health Science Futures (HSF) office: the Functional Repair of Neocortical […]

ARPA-H Announces the Functional Repair of Neocortical Tissue (FRONT) Program Read More »

DARPA’s CoasterChase Initiative

Leave a Comment / DARPA, Emerging Technologies / By Max Higgins, Consultant

CoasterChase – BIOLOGICAL TECHNOLOGIES OFFICE – HR001125S0014 Targeting Stress from the Inside Out: DARPA’s CoasterChase Initiative The Defense Advanced Research Projects Agency (DARPA) continues to push the boundaries of biomedical technology with the release of its latest Broad Agency Announcement (BAA), HR001125S0014, titled CoasterChase. Issued by DARPA’s Biological Technologies Office (BTO), this program seeks to

DARPA’s CoasterChase Initiative Read More »

BARDAs Strategic Investment in Enzymatic Debridement Products

Leave a Comment / BARDA, Life Sciences / By Max Higgins, Consultant

Advancing Burn Care Preparedness: BARDA’s Strategic Investment in Enzymatic Debridement Products In its ongoing mission to strengthen the nation’s biodefense and emergency response infrastructure, the Biomedical Advanced Research and Development Authority (BARDA), an office within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services, has released a

BARDAs Strategic Investment in Enzymatic Debridement Products Read More »

Transparent ampules on a blue background

BARDA’s Call to Action Antibiotics for Treatment of Bacterial Pneumonia or Bloodstream Infections

Leave a Comment / All Posts, BARDA, Life Sciences / By Max Higgins, Consultant

Combating Resistant Infections: BARDA’s Push for Advanced Antibiotics The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), has released a pre-solicitation notice aimed at identifying qualified vendors to support the late-stage development, procurement, and stockpiling of antibiotics for critical public health threats. Targeted programs include

BARDA’s Call to Action Antibiotics for Treatment of Bacterial Pneumonia or Bloodstream Infections Read More »

BARDA’s Call to Action on Marburg and Sudan Virus Vaccines

Leave a Comment / BARDA, Life Sciences / By Max Higgins, Consultant

Preparing for the Next Biological Threat: BARDA’s Vaccine Initiative for MARV and SUDV The Biomedical Advanced Research and Development Authority (BARDA), operating under the U.S. Department of Health and Human Services (HHS), has issued a pre-solicitation notice signaling its intent to launch a major Request for Proposal (RFP) later this year. This effort, managed by

BARDA’s Call to Action on Marburg and Sudan Virus Vaccines Read More »

ARPA-H’s Scalable Solutions ISO

Leave a Comment / All Posts, ARPA-H, Life Sciences / By Max Higgins, Consultant

Mission Office Innovative Solutions Opening (ISO)– ARPA-H-SOL-24-105 – Amendment 02: June 06, 2025 The Advanced Research Projects Agency for Health (ARPA-H) officially released solicitation ARPA-H-SOL-24-105 under its Scalable Solutions Office (SSO), titled Mission Office Innovative Solutions Opening (ISO). This initiative aims to fuel bold, high-impact biomedical and health innovations that tackle persistent barriers in health

ARPA-H’s Scalable Solutions ISO Read More »

IBMSC RISE OTA Consortium RFI

Leave a Comment / All Posts, Life Sciences / By Max Higgins, Consultant

Request for Information – IBMSC Resilient Industry and Supply Chain Enterprise (RISE) OTA Consortium In June 2025, the U.S. Department of Health and Human Services (HHS) issued a Request for Information (RFI) through the Administration for Strategic Preparedness and Response’s (ASPR) Center for Industrial Base Management and Supply Chain (IBMSC). This RFI invites feedback from

IBMSC RISE OTA Consortium RFI Read More »

DARPA’s Ag x BTO Special Topic Calls for Agricultural Defense Innovations

Leave a Comment / DARPA, Emerging Technologies / By Max Higgins, Consultant

Special Topic: Ag x BTO To defend against threats to America’s agricultural infrastructure, the Defense Advanced Research Projects Agency (DARPA) has launched a new Special Topic Area (STA) through its Biological Technologies Office (BTO). Known as Ag x BTO, this initiative seeks to catalyze innovative approaches to defending the U.S. agricultural system from chemical, biological,

DARPA’s Ag x BTO Special Topic Calls for Agricultural Defense Innovations Read More »

Medicine capsules global health with geometric pattern digital r

ARPA-H’s Proactive Health Office ISO Amendment 2

Leave a Comment / All Posts, ARPA-H, Life Sciences / By Max Higgins, Consultant

PROACTIVE HEALTH OFFICE – MISSION OFFICE INNOVATIVE SOLUTIONS OPENING (ISO) – ARPA-H-SOL-24-106 – Amendment 02: June 06, 2025 The Advanced Research Projects Agency for Health (ARPA-H) has recently amended the Proactive Health Office (PHO) Innovative Solutions Opening (ISO). The PHO ISO invites novel and disruptive health innovations aimed at extending health spans and improving health

ARPA-H’s Proactive Health Office ISO Amendment 2 Read More »

Doctor holding augmented reality medical-related digital icons

ARPA-H Resilient Systems ISO

Leave a Comment / All Posts, ARPA-H, Life Sciences / By Max Higgins, Consultant

RESILIENT SYSTEMS OFFICE – MISSION OFFICE INNOVATIVE SOLUTIONS OPENING (ISO) – ARPA-H-SOL-24-103 – Amendment 02: June 06, 2025 The Advanced Research Projects Agency for Health (ARPA-H) has released Amendment 02 of its Innovative Solutions Opening (ISO) under the Resilient Systems Office (RSO), under Solicitation Number ARPA-H-SOL-24-103. a mission-focused solicitation designed to confront systemic challenges across

ARPA-H Resilient Systems ISO Read More »

Digital composite image of scientific experiment and dNA strands

ARPA-H Health Science Futures ISO

Leave a Comment / ARPA-H, Life Sciences / By Max Higgins, Consultant

Health Science Futures – MISSION OFFICE INNOVATIVE SOLUTIONS OPENING (ISO) ARPA-H-SOL-24-104 – Amendment 02: June 06, 2025 The Advanced Research Projects Agency for Health (ARPA-H) has released Amendment 02 of its Health Science Futures (HSF) Mission Office Innovative Solutions Opening (ISO), under Solicitation Number ARPA-H-SOL-24-104. As part of its mission to catalyze high-risk, high-reward research,

ARPA-H Health Science Futures ISO Read More »

ARPA-H’s Four Mission Offices Sharpen Their Vision with ISO Amendments

Leave a Comment / ARPA-H, Life Sciences / By Max Higgins, Consultant

On June 6, 2025, the Advanced Research Projects Agency for Health (ARPA-H) issued Amendment 02 to its four flagship Innovation Solutions Opening (ISO) solicitations: Health Science Futures (HSF), Proactive Health Office (PHO), Resilient Systems Office (RSO), and Scalable Solutions Office (SSO). These ISOs represent the core operational arms of ARPA-H’s mission to fund transformative, high-risk,

ARPA-H’s Four Mission Offices Sharpen Their Vision with ISO Amendments Read More »